• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nature's Sunshine Appoints Steven Fasching to Board of Directors

    11/11/24 4:05:00 PM ET
    $DECK
    $NATR
    Shoe Manufacturing
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $DECK alert in real time by email

    Steven Fasching, Director

    LEHI, Utah, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nature's Sunshine) (NASDAQ:NATR), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the appointment of Mr. Steven Fasching to its board of directors, effective November 6, 2024. Nature's Sunshine's board will now consist of nine directors with eight serving as independent directors.

    "We are delighted to welcome Steve to our expanded board of directors," said Richard D. Moss, Chairman of the Board for Nature's Sunshine. "He brings significant financial acumen and public company experience from well-known consumer brands and will be a valuable addition to our board. Steve's experience in finance will strengthen our leadership as we continue the transformation of our business."

    Since June 2018, Fasching has served as the Chief Financial Officer of Deckers Brands (NYSE:DECK), which includes iconic brands such as UGG®, Hoka® and Teva®. Fasching has held other senior positions at Deckers Brands since August 2011, including Vice President, Strategy & Investor Relations and Vice President, Strategic Financial Planning. Fasching has over 30 years of experience in long-term financial and strategic planning for multi-billion-dollar organizations. Fasching received a B.S. degree in Business Administration from Pepperdine University and an M.B.A. from The Anderson School of Management at UCLA. He also completed The Executive Program for Prospective Chief Financial Officers through the University of Chicago Booth School of Business.

    About Nature's Sunshine

    Nature's Sunshine Products (NASDAQ:NATR), a leading natural health and wellness company, markets and distributes nutritional and personal care products in more than 40 countries. Nature's Sunshine manufactures most of its products through its own state-of-the-art facilities to ensure its products continue to set the standard for the highest quality, safety, and efficacy on the market today. Additional information about the Company can be obtained at its website, www.naturessunshine.com.

    Investor Relations

    Gateway Group, Inc.

    Cody Slach

    1-949-574-3860

    [email protected]

    A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/851f1698-5928-4576-8d35-745869a4dcdf



    Primary Logo

    Get the next $DECK alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DECK
    $NATR

    CompanyDatePrice TargetRatingAnalyst
    Deckers Outdoor Corporation
    $DECK
    2/20/2026Hold → Buy
    Argus
    Deckers Outdoor Corporation
    $DECK
    1/30/2026$105.00 → $120.00Market Perform
    Telsey Advisory Group
    Deckers Outdoor Corporation
    $DECK
    1/14/2026$102.00Hold
    Jefferies
    Deckers Outdoor Corporation
    $DECK
    1/7/2026$85.00Neutral → Underweight
    Piper Sandler
    Deckers Outdoor Corporation
    $DECK
    1/7/2026$125.00Outperform → Neutral
    Robert W. Baird
    Deckers Outdoor Corporation
    $DECK
    12/10/2025Neutral
    Guggenheim
    Deckers Outdoor Corporation
    $DECK
    11/18/2025$117.00Hold → Buy
    Stifel
    Deckers Outdoor Corporation
    $DECK
    10/24/2025$120.00 → $105.00Market Perform
    Telsey Advisory Group
    More analyst ratings

    $DECK
    $NATR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Nature's Sunshine Products Inc.

    4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

    3/10/26 5:42:18 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP & President, North America Herbert Kevin R. covered exercise/tax liability with 368 shares, was granted 7,124 shares and converted options into 1,239 shares, increasing direct ownership by 19% to 50,610 units (SEC Form 4)

    4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

    3/10/26 5:41:47 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Nature's Sunshine Products Inc.

    4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

    3/10/26 5:40:02 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DECK
    $NATR
    SEC Filings

    View All

    SEC Form 10-K filed by Nature's Sunshine Products Inc.

    10-K - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

    3/10/26 5:10:54 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nature's Sunshine Products Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits

    8-K - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

    3/10/26 5:00:59 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-Q filed by Deckers Outdoor Corporation

    10-Q - DECKERS OUTDOOR CORP (0000910521) (Filer)

    2/3/26 11:42:49 AM ET
    $DECK
    Shoe Manufacturing
    Consumer Discretionary

    $DECK
    $NATR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Davis Cindy L bought $200,319 worth of shares (1,825 units at $109.76), increasing direct ownership by 16% to 13,340 units (SEC Form 4)

    4 - DECKERS OUTDOOR CORP (0000910521) (Issuer)

    6/6/25 7:31:48 PM ET
    $DECK
    Shoe Manufacturing
    Consumer Discretionary

    $DECK
    $NATR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Deckers Outdoor upgraded by Argus

    Argus upgraded Deckers Outdoor from Hold to Buy

    2/20/26 8:19:35 AM ET
    $DECK
    Shoe Manufacturing
    Consumer Discretionary

    Telsey Advisory Group reiterated coverage on Deckers Outdoor with a new price target

    Telsey Advisory Group reiterated coverage of Deckers Outdoor with a rating of Market Perform and set a new price target of $120.00 from $105.00 previously

    1/30/26 6:49:41 AM ET
    $DECK
    Shoe Manufacturing
    Consumer Discretionary

    Jefferies resumed coverage on Deckers Outdoor with a new price target

    Jefferies resumed coverage of Deckers Outdoor with a rating of Hold and set a new price target of $102.00

    1/14/26 8:40:20 AM ET
    $DECK
    Shoe Manufacturing
    Consumer Discretionary

    $DECK
    $NATR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nature's Sunshine Reports Strong Fourth Quarter and Full Year 2025 Financial Results

    LEHI, Utah, March 10, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine" and/or the "Company"), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Summary vs. Same Year-Ago Quarter Net sales were up 4.7% to $123.8 million compared to $118.2 million (up 3.8% in constant currency).GAAP net income attributable to common shareholders of $4.1 million, or $0.23 per diluted share, compared to net loss of $0.3 million, or $(0.02) per diluted share.Adjusted EBITDA up 16% to $11.9 million compar

    3/10/26 4:05:00 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Teva Unveils Spring 2026 Collection: "For Playground Earth" Evolves for Wherever Adventure Leads

    New performance and lifestyle footwear designed to equip people to play outside Teva®, a division of Deckers Brands (NYSE:DECK), introduces its Spring 2026 collection, the next evolution of its For Playground Earth platform. The S26 lineup serves as your companion for outdoor adventure, merging performance technology with design innovation to inspire and support exploration and connection across the world's natural playgrounds — from summits to riversides. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260303926599/en/Teva updates fan-favorite Hurricane collection with three new styles "For Playground Earth" is more than just

    3/3/26 9:00:00 AM ET
    $DECK
    Shoe Manufacturing
    Consumer Discretionary

    Nature's Sunshine Sets Fourth Quarter 2025 Conference Call for Tuesday, March 10, 2026, at 5:00 p.m. ET

    LEHI, Utah, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine") (the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, will conduct a conference call on Tuesday, March 10, 2026, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the fourth quarter and full year ended December 31, 2025. The Company will report its financial results in a press release prior to the conference call. Nature's Sunshine CEO Kenneth Romanzi and CFO Shane Jones will host the conference call, followed by a question and answer period. Date: Tuesday, March 10, 2026Time: 5:00 p.m. Eastern time

    2/24/26 4:05:00 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DECK
    $NATR
    Leadership Updates

    Live Leadership Updates

    View All

    Nature's Sunshine Appoints Erich Fritz as Executive Vice President of Global Supply Chain

    LEHI, Utah, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine") (the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, today announced that Erich Fritz has been named Executive Vice President, Global Supply Chain, effective December 8, 2025. Mr. Fritz will report directly to Ken Romanzi, the Company's Chief Executive Officer. Mr. Fritz brings over 40 years of executive experience in operations, supply chain, and business development, with a proven track record of driving growth, operational efficiency, and innovation at leading consumer goods companies. His leadership spans Fortune 500 organizations an

    12/4/25 10:00:00 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nature's Sunshine Appoints Kenneth Romanzi as CEO

    Mr. Romanzi Brings Extensive Leadership and Operational Experience at Prominent, Large-Scale Consumer Packaged Goods Companies and Proven Track Record of Driving Growth and Value Creation LEHI, Utah, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine") (the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, today announced that its Board of Directors has appointed Kenneth Romanzi to succeed Terrence Moorehead as Chief Executive Officer. Mr. Romanzi will assume the role and become a member of the Nature's Sunshine Board of Directors on October 29, 2025. Mr. Romanzi is an experienced CEO and operator with

    10/15/25 9:00:00 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Deckers Brands Nominates Patrick J. Grismer to Board of Directors

    Dave Powers to Retire from the Board After Over Nine Years of Service Deckers Brands (NYSE:DECK), a global leader in designing, marketing, and distributing innovative footwear, apparel, and accessories, today announced the nomination of Patrick J. Grismer for election to its Board of Directors (the "Board") at the Company's 2025 Annual Meeting of Stockholders to be held on September 8, 2025 (the "Annual Meeting"). In connection with Mr. Grismer's nomination and as previously announced, Dave Powers will not stand for reelection to the Board at the Annual Meeting, retiring after more than nine years of service as a director. Mr. Grismer brings over 35 years of financial leadership experie

    7/24/25 4:10:00 PM ET
    $DECK
    Shoe Manufacturing
    Consumer Discretionary

    $DECK
    $NATR
    Financials

    Live finance-specific insights

    View All

    Nature's Sunshine Reports Strong Fourth Quarter and Full Year 2025 Financial Results

    LEHI, Utah, March 10, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine" and/or the "Company"), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Summary vs. Same Year-Ago Quarter Net sales were up 4.7% to $123.8 million compared to $118.2 million (up 3.8% in constant currency).GAAP net income attributable to common shareholders of $4.1 million, or $0.23 per diluted share, compared to net loss of $0.3 million, or $(0.02) per diluted share.Adjusted EBITDA up 16% to $11.9 million compar

    3/10/26 4:05:00 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nature's Sunshine Sets Fourth Quarter 2025 Conference Call for Tuesday, March 10, 2026, at 5:00 p.m. ET

    LEHI, Utah, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine") (the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, will conduct a conference call on Tuesday, March 10, 2026, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the fourth quarter and full year ended December 31, 2025. The Company will report its financial results in a press release prior to the conference call. Nature's Sunshine CEO Kenneth Romanzi and CFO Shane Jones will host the conference call, followed by a question and answer period. Date: Tuesday, March 10, 2026Time: 5:00 p.m. Eastern time

    2/24/26 4:05:00 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Deckers Brands Reports Third Quarter Fiscal Year 2026 Financial Results

    Third Quarter FY 2026 Revenue Increased 7% to a Record $1.96 Billion Third Quarter FY 2026 Diluted EPS Increased 11% to a Record $3.33 FY 2026 HOKA Revenue Guidance Raised to Mid-teens Percent Increase FY 2026 UGG Revenue Guidance Raised to Mid-single-digits Percent Increase FY 2026 Diluted EPS Guidance Raised to Range of $6.80-$6.85 FY 2026 Share Repurchase Expected to Exceed $1.0 Billion Deckers Brands (NYSE:DECK), a global leader in designing, marketing, and distributing innovative footwear, apparel, and accessories, today announced financial results for the third fiscal quarter ended December 31, 2025. The Company also provided an update to its financial outlook for t

    1/29/26 4:05:00 PM ET
    $DECK
    Shoe Manufacturing
    Consumer Discretionary

    $DECK
    $NATR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Deckers Outdoor Corporation (Amendment)

    SC 13G/A - DECKERS OUTDOOR CORP (0000910521) (Subject)

    4/10/24 2:03:52 PM ET
    $DECK
    Shoe Manufacturing
    Consumer Discretionary

    SEC Form SC 13G/A filed by Deckers Outdoor Corporation (Amendment)

    SC 13G/A - DECKERS OUTDOOR CORP (0000910521) (Subject)

    2/13/24 5:02:34 PM ET
    $DECK
    Shoe Manufacturing
    Consumer Discretionary

    SEC Form SC 13G/A filed by Nature's Sunshine Products Inc. (Amendment)

    SC 13G/A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Subject)

    2/12/24 10:37:49 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care